Celebrating World Hepatitis Day and the legacy, and 100th birthday,

of Baruch S. Blumberg, MD, DPhil

The birthday of Baruch S. Blumberg, MD, DPhil, Nobel Laureate and global health pioneer, is celebrated annually around the globe on July 28, which is designated World Hepatitis Day in his honor. This year we commemorated his 100th birthday with an event in Doylestown, Pa., on July 28 and another in Philadelphia the next day.


Sir Mark Thompson, the event's keynote speaker and CEO of CNN, is seen here with a pair of hiking boots worn extensively by Dr. Blumberg, his father-in-law.


Dr. Blumberg discovered the hepatitis B virus, co-invented a blood test for it and worked with colleagues to develop the first HBV vaccine.

A high-quality video recording of the event is posted here.

More than 100 of Dr. Blumberg's former colleagues, friends and family members attended the event.


In addition to Sir Mark, the audience heard from Harvey Alter, MD, a Nobel Laureate, scientist and former collaborator of Dr. Blumberg.

A panel discussion about the impact of Dr. Blumberg's work and the current realities of hepatitis B worldwide filled out the program. Please read more here.

 

For World Hepatitis Day, our team contributes to two major journal articles

Two new articles focused on hepatitis B treatment expansion were published in The Lancet Gastroenterology &Hepatology in time for World Hepatitis Day. The Hepatitis B Foundation participated in these articles, which were commissioned by the International Coalition to Eliminate-HBV (ICE-HBV).

 

These new papers call for expanding treatment eligibility and earlier intervention for people living with hepatitis B — grounded in scientific evidence, patient perspectives and public health impact.



In recognition of Immunization Awareness Month:

Protecting children with the hepatitis B birth dose

In a follow-up to their first story, Janet and Kurt share their gratitude that their daughter is healthy and free of hepatitis B, thanks to receiving the birth dose shortly after birth.


Their story underscores that hepatitis B is entirely preventable and that the birth dose is a powerful tool to safeguard children—especially those most vulnerable in early life. They encourage parents to seek vaccine education from reputable sources and make informed decisions to protect their children from liver cancer.

Watch their first video here.

New African Hepatitis B Advocacy Coalition website

Our team just launched a new website for the African Hepatitis B Advocacy Coalition (ABAC), a major, multiyear investment to deliver a new program supporting hepatitis B elimination on the continent.

The Foundation staff has been working there with strong local partners in more than 12 countries to develop models for prevention, education testing and linkage to care.

WHO calls for action on hepatitis, calling special attention to hepatitis D

On World Hepatitis Day this year, the World Health Organization (WHO) called for action by governments and partners to "urgently accelerate efforts to eliminate viral hepatitis as a public health threat and reduce liver cancer deaths."


WHO officials pointed to a recent announcement by the International Agency for Research on Cancer that is classified hepatitis D as carcinogenic to humans. Read more here.

Explore the Hep-CARE map:

Connecting communities to hepatitis B & C care

The Hepatitis Community Access Resource for Elimination (Hep-CARE) map highlights recipients of the CDAF-Relink grant, who are working to reconnect individuals diagnosed—but not yet treated—for hepatitis B and C back to care across the U.S.


The map also features locations shared by CDAF-Relink grantees that offer hepatitis B and C testing, treatment, and related resources.


Disclaimer: This map is intended for general informational purposes and does not represent a complete or exhaustive listing of all relevant locations in the U.S.

Click on the map to enlarge.

If your organization provides hepatitis B or C services and you would like to be added to the map, please submit your request here.

We want to hear from YOU


Please take a moment to complete our reader survey and let us know how we’re doing. Your feedback helps us deliver the content that you find to be most valuable. Please take the brief survey here. Thank you for being a valued part of our community!

Help us make B News even better.
Positive        Neutral        Negative

New Hep B Blog | How to tell your partner, family, or friends

about your hepatitis B or D status: Tips and tricks

Disclosing your hepatitis B or D status can be difficult, but preparation can help make the conversation more comfortable and productive. Choose a calm, private moment, and talk with someone you trust. Be ready to share the facts about the virus, how it is transmitted, and how it is managed—most people don’t know much about hepatitis B or D. Focus on your health, reassure them about prevention, and let them know what kind of support you hope for.

 

Remember, you decide how much to share and when. With the right information, understanding can grow, stigma can fade, and this step can become one of empowerment and connection. Read the full blog here.

New B Heppy podcast episodes

Integrating hepatitis B into primary care: Lessons from the Philippines and Vietnam

Dr. Bethany Holt and Imee Lacson

In this episode, Bright and Anousha speak with Dr. Bethany Holt, Associate Director of Health Systems at Harvard Medical School’s Program in Global Primary Health Care, and Imee Lacson, a patient advocate with the Yellow Warriors Society.


Together, they discuss how hepatitis B can be integrated into primary care and share strategies for strengthening health systems to address the disease in the Philippines and Vietnam. Listen here.

Why the first shot matters: Confronting hepatitis B birth dose hesitancy

Dr. David Higgins

In this episode, Bright and Anousha invited Dr. David Higgins, a pediatrician and leading expert in vaccine delivery and communication from University of Colorado Anschutz Medical Campus.


He sheds light on common myths and misconceptions about the hepatitis B birth dose and offers practical strategies for healthcare providers and advocates to address concerns with parents using empathy and evidence-based science. Listen here.

Voices of Strength: Inspiring journeys with hepatitis B and D

From navigating care across continents to finding the courage to speak out, these powerful stories highlight the resilience of those living with hepatitis B and D.


Lynette trusted her instincts despite conflicting advice, starting early treatment that later protected her liver through cancer care. MW faced stigma after diagnosis but found hope in support from a loved one, inspiring her to raise awareness and help her family get tested. Sisters Dilnora and Dilrabo turned personal challenges into advocacy—launching support groups, pursuing health education, and showing the vital role of community, mental health and self-care.


Together, their journeys remind us that early treatment, support and speaking up can change lives.

Video spotlight: The fight against hepatitis B explained

 

Join Philippa Matthews, scientist and infectious diseases consultant, as she explores both the scientific and social challenges of addressing hepatitis B. Affecting almost 300 million people worldwide, hepatitis B is a major yet underfunded global health threat. Many living with the virus face delayed diagnosis, limited access to care and persistent stigma.


In her lab at the Francis Crick Institute, Philippa studies the biology of the virus and works to develop clinical strategies for better diagnosis, prevention and treatment.

Upcoming webinar: EASL 2025 hepatitis B guidelines -

key updates and clinical implications

Panelists:

 

The European Association for the Study of the Liver (EASL) has released its updated 2025 Clinical Practice Guidelines on Hepatitis B—bringing important changes that will shape diagnosis, treatment and long-term care.


Join us for an in-depth overview of these updates and what they mean for day-to-day clinical decision-making. This session will cover:

  • Key diagnostic changes and their practical application,
  • Evolving treatment strategies for different patient populations,
  • Long-term management and monitoring recommendations and
  • Implications for healthcare providers, community health and people with lived experience.

Thursday, Sept. 4, 2025

11:30 a.m. EST | 4:30 p.m. GMT

Join us for the 2025 HBV Community Forum in Berlin or online

The 2025 Hepatitis B Community Forum will be a hybrid event on Sept. 8 in Berlin, Germany, just prior to the opening session of the International HBV Meeting. This unique event brings together scientists, public health professionals and people living with hepatitis B and D to exchange knowledge, share lived experiences and strengthen collaboration in the fight against HBV.

Let’s work together to fast-track a cure and build a world free from HBV-related stigma.

  • Hybrid event
  • No charge to attend

Hepatitis B Foundation now accepts crypto donations

You can now donate cryptocurrency to the Hepatitis B Foundation via The Giving Block! Your crypto gift helps advance research, patient advocacy and global efforts to eliminate hepatitis B—quickly, securely, and with unique tax advantages.

 

Click here to learn more and make your crypto gift today!

Learn more about our research and education programs at www.hepb.org

The Hepatitis B Foundation is a global nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. Our commitment includes funding focused research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as the primary source of information for patients and their families, the medical and scientific community and the general public.

Facebook  Twitter  Instagram  Youtube